Skip to main content
OpenTrials

Clinical trial condition

Chronic Obstructive Pulmonary Disease (COPD)

Explore clinical trials studying Chronic Obstructive Pulmonary Disease (COPD). Study availability and eligibility vary by location and protocol.

428 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Chronic Obstructive Pulmonary Disease (COPD) trial results

Completed

A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation

NCT01682863

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Vestavia Hills, Alabama, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Lakewood, California, United States
  • Novartis Investigative Site Los Angeles, California, United States
View all 86 locations
View Trial Details
Completed

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

NCT01727141

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Montgomery, Alabama, United States
  • Novartis Investigative Site Mesa, Arizona, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
View all 143 locations
View Trial Details
Completed

Long Term Safety Study of NVA237 vs QAB149 in COPD Patients

NCT01697696

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Gulf Shores, Alabama, United States
  • Novartis Investigative Site Mobile, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Riverside, California, United States
View all 61 locations
View Trial Details
Completed

Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01908140

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Site Feldbach, Austria
  • Almirall Investigational Site Feldkirch, Austria
  • Almirall Investigational Site Grieskirchen, Austria
  • Almirall Investigational Site Linz, Austria
View all 126 locations
View Trial Details
Completed

The COPD Patient Management European Trial (COMET)

NCT01241526

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Centre Hospitalier d Antibes Juans-les-pins Antibes, France
  • Hôpitaux Civils de Colmar - Hôpital Pasteur Colmar, France
  • CHU de Grenoble Grenoble, France
  • Centre Hospitalier du Mans Le Mans, France
View all 34 locations
View Trial Details

Related conditions